News

Latest news

Patents&Certificate: AI-based spinal disease diagnosis/treatment, outstanding corporate contributor in Invention Promotion Act

Our organization has proudly received the certification as an Outstanding Corporate Contributor in Employee Invention Compensation, recognizing our commitment to fostering innovation and rewarding employee contributions to technological advancements. This prestigious recognition is based on the successful registration of two significant patents that showcase our leadership in combining artificial intelligence and expert knowledge to address critical challenges in spinal disease management:


Patent No.: 10-2723990

Application No.: 10-2024-0090994

Registration Date: October 25, 2024

Title: Method and Device for Providing Diagnostic Information About Spinal Diseases Using a Natural Language Processing Model Related to Spinal Diseases

Abstract: This patent introduces an advanced system for diagnosing spinal diseases by utilizing a specialized natural language processing (NLP) model trained on spinal disease-related data. The innovation enhances diagnostic accuracy and efficiency, empowering healthcare professionals with timely and precise diagnostic information.


Patent No.: 10-2723991

Application No.: 10-2024-0090995

Registration Date: October 25, 2024

Title: Method and Device for Providing Treatment Information About Spinal Diseases Using a Decision Tree Model Based on Expert Knowledge

Abstract: This patent focuses on providing optimized treatment solutions for spinal diseases by leveraging a decision tree model created in collaboration with expert knowledge. It ensures that patients receive the most effective, evidence-based therapeutic options, elevating the standard of care in spinal disease treatment.


These patents reflect our dedication to integrating cutting-edge technology with expert insights to drive innovation in healthcare. This certification underscores our efforts to create a culture that values and rewards employee contributions to transformative advancements, reinforcing our role as a leader in medical technology innovation.